Open Access

[Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4

  • Authors:
    • Jing-Meng Hu
    • Li-Jie He
    • Peng-Bo Wang
    • Yan Yu
    • Ya-Ping Ye
    • Li Liang
  • View Affiliations

  • Published online on: January 29, 2024     https://doi.org/10.3892/ijmm.2024.5353
  • Article Number: 29
  • Copyright : © Hu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Int J Mol Med 48: [Related article:] 169, 2021; DOI: 10.3892/ijmm.2021.5002

Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the EdU staining assay data shown in Figs. 4C and 5C and the western blotting data shown in Fig. 4E were strikingly similar to data appearing in different form in other research articles written by different authors at different research institutes that had either already been published, or were submitted for publication at around the same time.

Owing to the fact that contentious data in the above article had already been submitted for publication elsewhere prior to its submission to International Journal of Molecular Medicine, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

March-2024
Volume 53 Issue 3

Print ISSN: 1107-3756
Online ISSN:1791-244X

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Hu J, He L, Wang P, Yu Y, Ye Y and Liang L: [Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4<em></em>. Int J Mol Med 53: 29, 2024
APA
Hu, J., He, L., Wang, P., Yu, Y., Ye, Y., & Liang, L. (2024). [Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4<em></em>. International Journal of Molecular Medicine, 53, 29. https://doi.org/10.3892/ijmm.2024.5353
MLA
Hu, J., He, L., Wang, P., Yu, Y., Ye, Y., Liang, L."[Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4<em></em>". International Journal of Molecular Medicine 53.3 (2024): 29.
Chicago
Hu, J., He, L., Wang, P., Yu, Y., Ye, Y., Liang, L."[Retracted] Antagonist targeting miR‑106b‑5p attenuates acute renal injury by regulating renal function, apoptosis and autophagy via the upregulation of TCF4<em></em>". International Journal of Molecular Medicine 53, no. 3 (2024): 29. https://doi.org/10.3892/ijmm.2024.5353